T-cell responses in photoimmune therapy
β Scribed by Peter W. Heald; Hong Yong Kim; Maritza Perez; Richard L. Edelson; Carole L. Berger
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 685 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0733-2459
No coin nor oath required. For personal study only.
β¦ Synopsis
The extracorporeal inactivation of a lymphocyte rich buffy coat suspension with ultraviolet A light and 8 methoxypsoralen can lead to dramatic clinical improvements following reinfusion of the damaged cells. This therapy is reviewed in the context of the disease it is most commonly used for: cutaneous lymphoma. Studies with cutaneous lymphoma patients have shown an active immune response against purified tumor cells. In addition a mouse model for an impact of therapy on a T-cell lymphoma has demonstrated results that parallel those from clinical studies in humans. The impact of photoimmune therapy on in vivo and in vitro T-cell responses to cutaneous lymphoma is discussed.
π SIMILAR VOLUMES
## Abstract ## Introduction: Enzyme replacement therapy (ERT) in ultraβorphan Pompe disease generates antiβrhGAA antibodies, which may interfere with efficacy. ## Methods: rhGAAβspecific Tβcell responses were examined at different timeβpoints in 6 Hungarian patients treated with rhGAA and compar
Antigen-specific T cell responses have primarily been considered in terms of activation signals delivered through the TCR and the co-stimulatory molecule CD28. In the past few years, studies have demonstrated the critical importance of inhibitory signals for regulating lymphocyte activation. CD28 an